BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced.
Options
BORIS DOI
Date of Publication
September 2021
Publication Type
Article
Division/Institute
Author
Kündig, Thomas M | |
Subject(s)
Series
Allergy
ISSN or ISBN (if monograph)
1398-9995
Publisher
Wiley
Language
English
Publisher DOI
PubMed ID
33948956
Uncontrolled Keywords
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| Allergy_-_2021_-_Chang_-_BNT162b2_mRNA_..._cross_reactivity_than_natural__1_.pdf | text | Adobe PDF | 976.48 KB | published |